Elin Bernson

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Natural Killer Cells

Top Venues

Chemical science

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson, Yongjin Xu, Linnea Kristenson, Tord Inghardt, Thomas Lundbäck, Fredrik Bergh Thorén, Morten Grøtli, Joakim Andréasson
All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical science 15 (18) (2024)
Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson, Yongjin Xu, Linnea Kristenson, Tord Inghardt, Thomas Lundbäck, Fredrik Bergh Thorén, Morten Grøtli, Joakim Andréasson
All-photonic kinase inhibitors: light-controlled release-and-report inhibition. Chemical science 15 (18) (2024)
Elin Bernson, Oisín Huhn, Veronika Karlsson, Delia Hawkes, Maria Lycke, Valentina Cazzetta, Joanna Mikulak, James Hall, Anna M Piskorz, Rosalba Portuesi, Domenico Vitobello, Barbara Fiamengo, Gabriele Siesto, Amir Horowitz, Hormas Ghadially, Domenico Mavilio, James D Brenton, Karin Sundfelt, Francesco Colucci
Identification of Tissue-Resident Natural Killer and T Lymphocytes with Anti-Tumor Properties in Ascites of Ovarian Cancer Patients. Cancers 15 (13) (2023)
Brwa Ali Hussein, Linnea Kristenson, Silvia Pesce, Anne Wöhr, Yarong Tian, Alexander Hallner, Mats Brune, Kristoffer Hellstrand, Ka-Wei Tang, Elin Bernson, Fredrik Bergh Thorén
NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells. Journal for immunotherapy of cancer 11 (8) (2023)
Alexander Hallner, Elin Bernson, Brwa Ali Hussein, Frida Ewald Sander, Mats Brune, Johan Aurelius, Anna Martner, Kristoffer Hellstrand, Fredrik Bergh Thorén
The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia. Blood 133 (13) (2019)